You are here: Home / News / NICE update on Eteplirsen
NICE update on Eteplirsen
May 11, 2018 by abzali123
Following last week’s announcement that Sarepta’s exon skipping drug, Eteplirsen,had received a negative trend vote from the European Medicine Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP).
The company has been in touch with the National Institute for Health and Care Excellence (NICE),to inform them of the anticipated delayed regulatory timings.As you know, NICE had scheduled to evaluate eteplirsen under their Highly Specialised Technology (HST) program this Summer.
The forthcoming submission deadline on 17 May 2018 and forthcoming committee discussion on 23 August 2018, will be revised for HST evaluation. NICE hope to communicate the revised submission deadline and first committee discussion date by mid-June 2018 to the stakeholders,including the UK patient organisations involved in the appraisal process.
We understand and feel the Duchenne communities’ frustration at the delays. We wish to thank all those who have shared their personal perspectives and journey’s to date and we will continue to work with our charity partners in the UK and Internationally to continue to ensure your voices are heard and address the challenges faced ahead together.
If you have any questions, we would be delighted to hear from you, please feel free to get in touch with our Director of Research, Neil Bennett neil@actionduchenne.org or reach us at Head Office on 020 7250 8240.
Like most websites we use cookies to deliver a personalised service. To use the website as intended please accept cookies.
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.